Clinical trial
Study to Evaluate Blood Cell Lines From Patients With Gaucher Disease
NCT00351156 · Amicus Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00351156 |
|---|---|
| Title | Study to Evaluate Blood Cell Lines From Patients With Gaucher Disease |
| Official title | A Multicenter Study to Evaluate and Characterize the Ex Vivo Effect of Pharmacological Chaperone Therapy in Blood Cell Lines Derived From Patients With Gaucher Disease |
| Lead sponsor | Amicus Therapeutics, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Gaucher Disease |
| Intervention type | Procedure |
| Interventions | Blood sample |
| Enrollment | 50 |
| Start date | Jul 1, 2006 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Jul 12, 2006 |
| Last update posted | Aug 19, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: